Compounds > 5-(2,3,5-trichlorophenyl)pyrimidine-2,4-diamine ethane sulfonate
Page last updated: 2024-09-03

5-(2,3,5-trichlorophenyl)pyrimidine-2,4-diamine ethane sulfonate and 1-methyl-3-isobutylxanthine

5-(2,3,5-trichlorophenyl)pyrimidine-2,4-diamine ethane sulfonate has been researched along with 1-methyl-3-isobutylxanthine in 1 studies

Compound Research Comparison

Studies
(5-(2,3,5-trichlorophenyl)pyrimidine-2,4-diamine ethane sulfonate)		Trials
(5-(2,3,5-trichlorophenyl)pyrimidine-2,4-diamine ethane sulfonate)		Recent Studies (post-2010)
(5-(2,3,5-trichlorophenyl)pyrimidine-2,4-diamine ethane sulfonate)		Studies
(1-methyl-3-isobutylxanthine)		Trials
(1-methyl-3-isobutylxanthine)		Recent Studies (post-2010) (1-methyl-3-isobutylxanthine)
19005,1485279

Protein Interaction Comparison

ProteinTaxonomy5-(2,3,5-trichlorophenyl)pyrimidine-2,4-diamine ethane sulfonate (IC50)1-methyl-3-isobutylxanthine (IC50)
Chain A, High-affinity cAMP-specific 3',5'-cyclic phosphodiesterase 7AHomo sapiens (human)8.1
Chain A, cAMP-specific 3',5'-cyclic phosphodiesterase 4DHomo sapiens (human)31
Chain A, Phosphodiesterase 9AHomo sapiens (human)500
Chain A, Class I phosphodiesterase PDEB1Leishmania major580
Chain A, High affinity cAMP-specific and IBMX-insensitive 3',5'-cyclic phosphodiesterase 8AHomo sapiens (human)698
Chain A, cGMP-dependent 3',5'-cyclic phosphodiesteraseHomo sapiens (human)40
Chain A, High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9AHomo sapiens (human)117.2
Chain A, High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9AHomo sapiens (human)117.2
Phosphodiesterase Bos taurus (cattle)9.9
cGMP-dependent 3',5'-cyclic phosphodiesteraseHomo sapiens (human)4
cGMP-specific 3',5'-cyclic phosphodiesteraseHomo sapiens (human)3.1667
Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1A Bos taurus (cattle)9.9
Adenosine receptor A1Rattus norvegicus (Norway rat)7
Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1AHomo sapiens (human)3.4
Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1BBos taurus (cattle)9.9
Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1BHomo sapiens (human)3.4
Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1BRattus norvegicus (Norway rat)0.1
cGMP-inhibited 3',5'-cyclic phosphodiesterase BHomo sapiens (human)0.242
Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1CHomo sapiens (human)3.4
cGMP-inhibited 3',5'-cyclic phosphodiesterase AHomo sapiens (human)7
Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1CRattus norvegicus (Norway rat)0.1
Phosphodiesterase Rattus norvegicus (Norway rat)0.1

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Garthwaite, G; Garthwaite, J; Goodwin, DA1

Other Studies

1 other study(ies) available for 5-(2,3,5-trichlorophenyl)pyrimidine-2,4-diamine ethane sulfonate and 1-methyl-3-isobutylxanthine

ArticleYear
Nitric oxide stimulates cGMP formation in rat optic nerve axons, providing a specific marker of axon viability.
    The European journal of neuroscience, 1999, Volume: 11, Issue:12

    Topics: 1-Methyl-3-isobutylxanthine; Animals; Axons; Biomarkers; Cell Hypoxia; Cell Survival; Cyclic GMP; Glucose; Hydrazines; Immunohistochemistry; In Vitro Techniques; Neuroprotective Agents; Nitric Oxide; Nitrogen Oxides; Optic Nerve; Phosphodiesterase Inhibitors; Piperazines; Pyrimidines; Rats; Rats, Wistar

1999